Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-121742

Chief Development Officer sold 10,000 shares at $48.97 ($489,700)

  • Chief Development Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2024-11-01 Option exercise 10b5-1 +6,606 $21.65 $143,020 12,402 D: show line 1 in the form
Guyer William Chief Development Officer 2024-11-01 Sale 10b5-1 −6,606 $48.97 $323,496 5,796 D: show line 2 in the form
Guyer William Chief Development Officer 2024-11-04 Option exercise 10b5-1 +3,394 $21.65 $73,480 9,190 D: show line 3 in the form
Guyer William Chief Development Officer 2024-11-04 Sale 10b5-1 −3,394 $48.97 $166,204 5,796 D: show line 4 in the form
Open-market sales · 10,000 sh · avg $48.97 · $489,700

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Guyer William Chief Development Officer 2024-11-01 Option exercise · Stock option (right to buy) 10b5-1 −6,606 453,394 D: show line 5 in the form
Guyer William Chief Development Officer 2024-11-04 Option exercise · Stock option (right to buy) 10b5-1 −3,394 450,000 D: show line 6 in the form
Loading xslF345X05/ownership.xml…